Notable Analyst Rating Changes 8/13: MOLX, ULTR, GNLB Upgraded; LVLT, TJX, COMV Downgraded
More News related to ATHN
- Brean Murray Maintains a 'Buy' on athenahealth (ATHN); Lofty Valuation Surpassed Only by Lofty Goals
- athenahealth to Present at the 21st Annual Piper Jaffray Health Care Conference
- athenahealth to Host Second Annual Investor Summit
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Athenahealth (ATHN) Issued U.S. Patent for anthenaNet Rules Engine
More News related to COMV
- Macquarie Initiates Coverage on Comverge (COMV) with an Outperform
- Comverge (COMV) Continuing Lower as Ardour Analyst Cuts to Hold
- Comverge (COMV) Prices 2.4M Shares at $10.50/Share
- Comverge Announces Pricing of Underwritten Offering of Common Stock
- DTE Energy, Comverge and Itron Lead the Way in Investigating the Impact of PEV Charging on the Smart Grid
More News related to ELX
- Emulex to Present at Barclays Capital Global Technology Conference
- BLADE Network Technologies and Emulex Deliver Essential Networking Components for IBM BladeCenter Virtual Fabric
- Emulex Participating in This Week's FCoE FCIA Plugfest at UNH-IOL with OneConnect UCNA
- Emulex Selected by Sun Microsystems to Deliver New ExpressModule HBA for the Sun Blade(TM) Family of Servers
- Trading Outlook for Brocade Communications Systems Inc. Issued by StockPreacher.com
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Credit Suisse upgrades Molex (Nasdaq: MOLX) from Underperform to Neutral with a $26 price target.
UBS upgrades Ultrapertol (Nasdaq: ULTR) from Neutral to Buy. Price target $15.50.
Susquehanna upgrades Genelabs Technologies (NASDAQ: GNLB) to Positive with a $1 price target.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Oppenheimer downgrades Level 3 Communications (Nasdaq: LVLT) from Perform to Underperform, citing economic headlines.
Lazard Capital downgrades TJX Companies (NYSE: TJX) from Buy to Hold.
Goldman Sachs downgrades Comverge, Inc. (Nasdaq: COMV) from Buy to Neutral and cuts its price target to $7.50.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs upgrades Emulex (NYSE: ELX) from Neutral to Buy with a $16.50 price target.
Citi initiates coverage on Toll Bros. (NYSE: TOL) with a Buy. Price target $27.
Thomas Weisel initiates coverage on athenahealth (Nasdaq: ATHN) with an Overweight rating and $40 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+1.04
-0.88Related Entities
- Credit Suisse
- UBS
- Goldman Sachs
- Citi
- Lazard
- Thomas Weisel Partners Group
- Susquehanna International Group of Companies
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
